AGC Biologics has partnered with AAVantgarde Bio to manufacture its dual-vector AAV gene therapies targeting inherited retinal disorders. Leveraging the BravoAAV platform, the collaboration aims to advance complex treatments designed to restore vision in patients with genetic blindness.
AGC Biologics | 24/11/2025 | By Dineshwori | 104
AGC Biologics Completes New Manufacturing Site at Copenhagen Campus
AGC Biologics has completed its new manufacturing building at Copenhagen campus.
AGC Biologics | 12/06/2024 | By Aishwarya | 676
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project
AGC Biologics | 18/08/2023 | By Sudeep Soparkar | 472
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy